Patients with CD45 deficiency typically present with recurrent infections, which may be severe or life-threatening. These infections can affect various parts of the body, including the respiratory tract, skin, and gastrointestinal system. Other symptoms may include failure to thrive in infants, chronic diarrhea, and poor wound healing. Due to the immune system's compromised state, patients may also experience opportunistic infections, which are infections caused by organisms that usually do not cause disease in healthy individuals.

Diagnosing CD45 deficiency involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Blood tests are conducted to assess the levels and function of white blood cells. Flow cytometry, a technique used to analyze the physical and chemical characteristics of cells, can help identify the absence or malfunction of CD45 on the surface of white blood cells. Genetic testing is crucial to confirm the diagnosis by identifying mutations in the PTPRC gene, which encodes the CD45 protein.

The primary treatment for CD45 deficiency is hematopoietic stem cell transplantation (HSCT), which aims to restore normal immune function by replacing the defective immune cells with healthy ones from a donor. Supportive care is also essential and may include antibiotics to treat or prevent infections, immunoglobulin replacement therapy to boost the immune system, and nutritional support to ensure proper growth and development. Early diagnosis and treatment are critical to improving outcomes.

The prognosis for individuals with CD45 deficiency largely depends on the timing of diagnosis and the success of treatment. Without treatment, the condition can be life-threatening due to severe infections. However, with successful stem cell transplantation and appropriate supportive care, many patients can achieve a significant improvement in immune function and quality of life. Long-term follow-up is necessary to monitor for potential complications and ensure optimal health.

CD45 deficiency is caused by mutations in the PTPRC gene, which provides instructions for making the CD45 protein. This protein is essential for activating and regulating white blood cells, which are crucial for a functioning immune system. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to develop the disorder.

CD45 deficiency is an extremely rare condition, with only a few cases reported in the medical literature. Due to its rarity, the exact prevalence is unknown. It can affect individuals of any ethnic background, but the limited number of cases makes it challenging to determine specific demographic patterns. Increased awareness and genetic testing may lead to more accurate identification and reporting of cases in the future.

The pathophysiology of CD45 deficiency involves the disruption of normal immune cell signaling. CD45 is a critical regulator of T and B lymphocytes, types of white blood cells that play a central role in the immune response. Without functional CD45, these cells cannot effectively respond to infections, leading to the severe immunodeficiency observed in affected individuals. This impaired immune response results in increased susceptibility to infections and other immune-related complications.

Currently, there are no specific measures to prevent CD45 deficiency, as it is a genetic disorder. However, genetic counseling can be beneficial for families with a history of the condition. Prospective parents who are known carriers of the PTPRC gene mutation may consider genetic testing and counseling to understand the risks and options available, such as prenatal testing or preimplantation genetic diagnosis.

CD45 deficiency is a rare genetic disorder characterized by severe immunodeficiency due to mutations in the PTPRC gene. It presents with recurrent and severe infections, requiring a comprehensive diagnostic workup and treatment plan. Hematopoietic stem cell transplantation is the primary treatment, offering the potential for improved immune function and quality of life. Early diagnosis and intervention are crucial for a favorable prognosis.

For patients and families affected by CD45 deficiency, understanding the condition is essential. It is a genetic disorder that weakens the immune system, making individuals prone to infections. Diagnosis involves specialized tests, and treatment typically includes stem cell transplantation and supportive care. While the condition is serious, advancements in medical care offer hope for improved outcomes. Families may benefit from genetic counseling to understand the condition and explore their options.